XML 24 R13.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Note 5 - Supplemental Information | 9 Months Ended
--- | ---
Dec. 31, 2024
Notes to Financial Statements |
Supplemental Balance Sheet Disclosures [Text Block] | Note 5. Supplemental Information Inventories consisted of the following:
|  | December 31, 2024 |  |  | March 31, 2024 |
Raw materials |  | $ | 16,584 |  |  | $ | 18,335 |
Work in process |  |  | 400 |  |  |  | 1,256 |
Finished goods |  |  | 11,138 |  |  |  | 13,084 |
Total inventories |  | $ | 28,122 |  |  | $ | 32,675 |
Prepaid expenses and other current assets consisted of the following:
|  | December 31, 2024 |  |  | March 31, 2024 |
Prepaid expenses |  | $ | 3,251 |  |  | $ | 2,932 |
Deposits |  |  | 1,338 |  |  |  | 1,898 |
Prepaid income taxes |  |  | 5,682 |  |  |  | 1,237 |
Other current assets |  |  | 2,849 |  |  |  | 3,341 |
Total prepaid expenses and other current assets |  | $ | 13,120 |  |  | $ | 9,408 |
Accrued payroll and benefits consisted of the following:
|  | December 31, 2024 |  |  | March 31, 2024 |
Bonus payable |  | $ | 7,803 |  |  | $ | 3,838 |
Wages and paid-time-off payable |  |  | 3,600 |  |  |  | 3,072 |
Payroll related taxes |  |  | 1,954 |  |  |  | 1,956 |
Other benefits payable |  |  | 562 |  |  |  | 1,069 |
Total accrued payroll and benefits |  | $ | 13,919 |  |  | $ | 9,935 |
The increase in bonus payable is primarily due to our financial performance in fiscal year 2025 compared to fiscal year 2024. Other accrued expenses consisted of the following:
|  | December 31, 2024 |  |  | March 31, 2024 |
Accrued business taxes |  | $ | 5,505 |  |  | $ | 5,557 |
Current operating lease liabilities |  |  | 3,535 |  |  |  | 2,986 |
Income taxes payable |  |  | 1,364 |  |  |  | 1,615 |
Current acquisition-related holdbacks |  |  | 9,531 |  |  |  | 436 |
Other |  |  | 2,416 |  |  |  | 2,264 |
Total other accrued expenses |  | $ | 22,351 |  |  | $ | 12,858 |
The increase in other accrued expenses is primarily due to the reclassification of held back Belyntic and GKE acquisition-related consideration from noncurrent liabilities. Other noncurrent liabilities consisted of the following:
|  | December 31, 2024 |  |  | March 31, 2024 |
Noncurrent operating lease liabilities |  | $ | 12,361 |  |  | $ | 6,613 |
Noncurrent acquisition-related holdbacks |  |  | - |  |  |  | 8,792 |
Other |  |  | 92 |  |  |  | 208 |
Total other noncurrent liabilities |  | $ | 12,453 |  |  | $ | 15,613 |
The increase in operating lease liabilities is primarily attributable to the right of use asset associated with an operating lease for a facility used by our Biopharmaceutical Development for manufacturing and administrative purposes.
|  | Three Months Ended December 31, |  |  | Nine Months Ended December 31, |
|  | 2024 |  |  | 2023 |  |  | 2024 |  |  | 2023 |
Depreciation expense in cost of revenues |  | $ | 610 |  |  | $ | 788 |  |  | $ | 2,376 |  |  | $ | 2,117 |
Depreciation expense in operating expense |  |  | 496 |  |  |  | 286 |  |  |  | 1,652 |  |  |  | 782 |
Total depreciation expense |  | $ | 1,106 |  |  | $ | 1,074 |  |  | $ | 4,028 |  |  | $ | 2,899 |
The increase in depreciation expense for the three and nine months ended December 31, 2024 is primarily due to GKE's operations, which included $225 and $850 of depreciation expense, respectively.

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/210/tableOfContent + Details
Name: | us-gaap_SupplementalBalanceSheetDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration